1. Home
  2. VRAX vs OP Comparison

VRAX vs OP Comparison

Compare VRAX & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • OP
  • Stock Information
  • Founded
  • VRAX 2013
  • OP 2021
  • Country
  • VRAX United Kingdom
  • OP Greece
  • Employees
  • VRAX N/A
  • OP N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • OP
  • Sector
  • VRAX Health Care
  • OP
  • Exchange
  • VRAX Nasdaq
  • OP Nasdaq
  • Market Cap
  • VRAX 7.3M
  • OP 8.5M
  • IPO Year
  • VRAX 2022
  • OP N/A
  • Fundamental
  • Price
  • VRAX $1.80
  • OP $1.12
  • Analyst Decision
  • VRAX
  • OP
  • Analyst Count
  • VRAX 0
  • OP 0
  • Target Price
  • VRAX N/A
  • OP N/A
  • AVG Volume (30 Days)
  • VRAX 230.2K
  • OP 12.2K
  • Earning Date
  • VRAX 02-05-2025
  • OP 12-20-2024
  • Dividend Yield
  • VRAX N/A
  • OP N/A
  • EPS Growth
  • VRAX N/A
  • OP N/A
  • EPS
  • VRAX N/A
  • OP N/A
  • Revenue
  • VRAX $84,872.00
  • OP $25,729,000.00
  • Revenue This Year
  • VRAX $5,169.18
  • OP N/A
  • Revenue Next Year
  • VRAX $66.97
  • OP N/A
  • P/E Ratio
  • VRAX N/A
  • OP N/A
  • Revenue Growth
  • VRAX 7.03
  • OP 36.33
  • 52 Week Low
  • VRAX $0.60
  • OP $1.02
  • 52 Week High
  • VRAX $9.00
  • OP $3.15
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 43.63
  • OP 40.22
  • Support Level
  • VRAX $1.56
  • OP $1.11
  • Resistance Level
  • VRAX $1.86
  • OP $1.24
  • Average True Range (ATR)
  • VRAX 0.20
  • OP 0.05
  • MACD
  • VRAX -0.05
  • OP -0.00
  • Stochastic Oscillator
  • VRAX 32.05
  • OP 7.17

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.

Share on Social Networks: